Estados financieros detallados de Femasys Inc. (FEMY): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Femasys Inc. registró ingresos de $2.3M en el último ejercicio fiscal, con un CAGR de 5 años del 17.2%.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $929064 | $1.0M | $1.2M | $1.2M | $1.1M | $1.6M | $2.3M |
| Coste de Ventas | $223678 | $306533 | $370384 | $441938 | $380069 | $544903 | $872400 |
| Beneficio Bruto | $705386 | $731385 | $809305 | $764280 | $691901 | $1.1M | $1.4M |
| I+D | $6.9M | $4.1M | $4.1M | $5.8M | $7.2M | $8.2M | $7.6M |
| Generales y Administrativos | $4.8M | $2.9M | $4.5M | $6.0M | $7.5M | $10.4M | $11.1M |
| Gastos Operativos | $12.3M | $7.7M | $9.1M | $12.4M | $15.2M | $18.9M | $19.0M |
| Beneficio Operativo | -$11.6M | -$6.9M | -$8.3M | -$11.6M | -$14.5M | -$17.8M | -$17.6M |
| EBITDA | -$10.2M | -$5.8M | -$6.6M | -$10.5M | -$13.2M | -$16.3M | -$15.9M |
| Gastos por Intereses | $9972 | $12553 | $19226 | $13464 | $165390 | $1.6M | $1.9M |
| Beneficio Antes de Impuestos | -$11.3M | -$6.9M | -$7.5M | -$11.4M | -$14.2M | -$18.8M | -$18.6M |
| Impuestos | $3006 | $1800 | $4000 | $6300 | $4338 | $9602 | $1297 |
| Beneficio Neto | -$11.3M | -$6.9M | -$7.5M | -$11.4M | -$14.2M | -$18.8M | -$18.6M |
| BPA | $-19.20 | $-11.80 | $-12.80 | $-19.40 | $-18.60 | $-16.80 | $-9.40 |
| BPA Diluido | $-19.20 | $-11.80 | $-12.80 | $-19.40 | $-18.60 | $-16.80 | $-9.40 |
| Acciones en Circulación (Diluidas) | $588078 | $588078 | $590208 | $590208 | $769219 | $1.1M | $2.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $729394 | $813387 | $424889 | $331827 |
| Beneficio Bruto | $224480 | $936235 | $65833 | -$27229 |
| Beneficio Operativo | -$3.7M | -$4.6M | -$4.2M | -$5.1M |
| EBITDA | -$3.5M | -$3.3M | $1.2M | -$4.2M |
| Beneficio Neto | -$4.2M | -$4.0M | $328646 | -$4.5M |
| BPA | $-2.00 | $-1.33 | $0.10 | $-1.33 |
| BPA Diluido | $-2.00 | $-1.33 | $0.08 | $-1.33 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $6.4M | $3.3M | $24.8M | $13.0M | $21.7M | $3.5M | $9.3M |
| Inversiones a Corto | $998831 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $83554 | $125790 | $84258 | $77470 | $98906 | $488373 | $616600 |
| Inventario | $172497 | $131378 | $208270 | $436723 | $667118 | $3.0M | $5.7M |
| Activos Corrientes | $8.0M | $3.9M | $25.6M | $14.1M | $23.2M | $8.0M | $16.5M |
| Inmovilizado Material | $3.9M | $2.9M | $2.3M | $1.8M | $3.5M | $3.4M | $3.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $160592 | $65069 | $25093 | $3294 | 0 | $65918 | $134914 |
| Activos Totales | $12.6M | $7.6M | $28.6M | $16.9M | $27.8M | $12.4M | $20.7M |
| Cuentas por Pagar | $481099 | $674333 | $445522 | $510758 | $1.1M | $1.4M | $1.8M |
| Deuda a Corto | 0 | $630010 | $181123 | $141298 | 0 | $5.4M | 0 |
| Pasivos Corrientes | $1.3M | $2.9M | $1.7M | $1.5M | $3.1M | $8.6M | $3.6M |
| Deuda a Largo | 0 | $182490 | 0 | 0 | $4.3M | 0 | $3.2M |
| Pasivos Totales | $58.0M | $4.1M | $2.2M | $1.7M | $9.4M | $10.1M | $14.9M |
| Reservas | -$68.3M | -$75.2M | -$82.7M | -$94.1M | -$108.4M | -$127.2M | -$145.8M |
| Patrimonio Neto | -$45.4M | $3.5M | $26.3M | $15.2M | $18.4M | $2.3M | $5.9M |
| Deuda Total | $1.7M | $2.1M | $990214 | $543715 | $6.7M | $7.4M | $4.7M |
| Deuda Neta | -$5.7M | -$1.3M | -$23.8M | -$12.4M | -$15.0M | $4.0M | -$4.6M |
| Capital Circulante | $6.8M | $974598 | $23.9M | $12.6M | $20.1M | -$560420 | $12.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $4.6M | $9.3M | $5.4M | $1.4M |
| Activos Totales | $16.3M | $20.7M | $16.5M | $12.3M |
| Pasivos Totales | $11.7M | $14.9M | $9.2M | $8.3M |
| Patrimonio Neto | $4.6M | $5.9M | $7.3M | $4.0M |
| Deuda Total | $8.4M | $4.7M | $4.7M | $4.8M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$11.3M | -$6.9M | -$7.5M | -$11.4M | -$14.2M | -$18.8M | -$18.6M |
| Amortizaciones | $1.1M | $1.1M | $964287 | $889140 | $907985 | $872000 | $804281 |
| Compensación en Acciones | $358841 | $318640 | $193366 | $224939 | $675700 | $444147 | $790145 |
| Cambio en Capital Circulante | -$1.1M | $557962 | -$732716 | -$458267 | $1.2M | -$3.1M | -$2.1M |
| Flujo de Caja Operativo | -$11.0M | -$4.9M | -$7.9M | -$10.7M | -$11.3M | -$19.4M | -$18.7M |
| Inversiones (CapEx) | -$696499 | -$31681 | -$306868 | -$407475 | -$143917 | -$761706 | -$525007 |
| Adquisiciones | $103141 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$11.7M | -$5.0M | -$8.2M | -$11.1M | -$11.4M | -$20.2M | -$19.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.4M | -$4.2M | -$4.1M | -$3.9M |
| Inversiones (CapEx) | -$239816 | -$139840 | -$79143 | -$9397 |
| Flujo de Caja Libre | -$5.6M | -$4.3M | -$4.2M | -$3.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $174514 | 0 | $151608 | $210820 |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +11.7% | +13.7% | +2.2% | -11.1% | +52.0% | +40.8% |
| Crecimiento Beneficio Neto (anual) | | +38.7% | -9.0% | -51.2% | -25.0% | -32.1% | +1.0% |
| Crecimiento BPA (anual) | | +38.5% | -8.5% | -51.6% | +4.1% | +9.7% | +44.0% |
| Cambio en Acciones (anual) | | +0.0% | +0.4% | +0.0% | +30.3% | +44.7% | +77.6% |
| Crecimiento FCF (anual) | | +57.6% | -65.9% | -35.2% | -2.6% | -76.9% | +4.9% |
| Margen Bruto | 75.9% | 70.5% | 68.6% | 63.4% | 64.5% | 66.6% | 62.0% |
| Margen Operativo | -1252.6% | -668.0% | -706.7% | -961.7% | -1353.4% | -1091.8% | -767.0% |
| Margen EBITDA | -1094.0% | -558.8% | -555.3% | -869.3% | -1228.5% | -1002.5% | -692.7% |
| Margen Neto | -1213.3% | -666.2% | -639.0% | -944.6% | -1329.1% | -1155.0% | -812.3% |
| Margen FCF | -1259.6% | -478.3% | -698.3% | -923.5% | -1065.7% | -1240.3% | -837.9% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.1% | -0.1% | -0.0% | -0.1% | -0.0% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-19.90 | $-8.44 | $-13.96 | $-18.87 | $-14.85 | $-18.15 | $-9.72 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $588078 | $588078 | $590208 | $590208 | $769219 | $1.1M | $2.0M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Salud financiera
| Piotroski F-Score | 3 |
| Altman Z-Score | -10.88 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -12.50 | -20.34 | -6.09 | -0.93 | -1.05 | -1.31 | -1.23 |
| P/VC | -3.11 | 40.01 | 1.75 | 0.70 | 0.82 | 10.63 | 3.88 |
| P/V | 151.91 | 135.98 | 39.02 | 8.81 | 13.99 | 15.04 | 9.93 |
| Margen Bruto | 75.9% | 70.5% | 68.6% | 63.4% | 64.5% | 66.6% | 62.0% |
| Margen Operativo | -1252.6% | -668.0% | -706.7% | -961.7% | -1353.4% | -1091.8% | -767.0% |
| Margen Neto | -1213.3% | -666.2% | -639.0% | -944.6% | -1329.1% | -1155.0% | -812.3% |